Evidence map›Paper›PMID 28168757›Full record

ArticleBritish journal of clinical pharmacology2017

Medication-induced SIADH: distribution and characterization according to medication class.

Daniel Shepshelovich, Amir Schechter, Bronislava Calvarysky, Talia Diker-Cohen, Benaya Rozen-Zvi, Anat Gafter-Gvili

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in British journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Pathophysiology of Drug-Induced Hyponatremia.Journal of clinical medicine · 2022
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Psychotropic drug-induced hyponatremia: results from a drug surveillance program-an update.Journal of neural transmission (Vienna, Austria : 1996) · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Daniel ShepshelovichMedicine A, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
Amir SchechterMedicine A, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
Bronislava CalvaryskyMedicine A, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
Talia Diker-CohenMedicine A, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
Benaya Rozen-ZviDepartment of Nephrology, Rabin Medical Center, Petah-Tikva, Israel.
Anat Gafter-GviliMedicine A, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
Rabin Medical Center · ILHebrew University of Jerusalem · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe aims of the current study were to determine the distribution of aetiologies for the drug-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH) in hospitalized patients, and to characterize them according to the different drug groups.

methodsA single-centre retrospective study was carried out, including all patients diagnosed with SIADH in a large community hospital and tertiary centre between 1 January 2007 and 1 January 2013 who were treated with drugs known to be associated with SIADH. Two physicians reviewed every patient's medical file for predetermined relevant clinical data.

resultsThe study cohort included 198 patients who had SIADH and received drugs associated with SIADH. Most patients [146 (73.7%)] were diagnosed with drug-associated SIADH, while 52 (26.3%) were diagnosed with SIADH due to other aetiologies. The Naranjo algorithm differentiated well between the two groups (P < 0.001). Five drug classes (antidepressants, anticonvulsants, antipsychotic agents, cytotoxic agents and pain medications) were implicated in 82.3% of patients diagnosed with drug-associated SIADH. Specific serotonin reuptake inhibitors and carbamazepine were commonly implicated. There were no clinically significant differences in the characteristics or severity of SIADH according to drug class.

conclusionsThe clinical characteristics of SIADH caused by different drugs are comparable. Patients with SIADH treated with drugs from five common medication classes will probably be diagnosed with drug-induced SIADH. Physicians should be aware of the significance of these medication classes as SIADH aetiologies.

Indexed as

AgedAged, 80 and overAnalgesicsAnticonvulsantsAntidepressive AgentsAntineoplastic AgentsAntipsychotic AgentsCarbamazepineFemaleHospitalizationHumansHyponatremiaInappropriate ADH SyndromeMaleMiddle AgedRetrospective StudiesAnalgesicsAnticonvulsantsAntidepressive AgentsAntineoplastic AgentsAntipsychotic AgentsCarbamazepineSelective Serotonin Reuptake InhibitorsdistributionhyponatraemiamedicationsSIADH

Identifiers

PMID28168757
PMCPMC5510077
OpenAlexW2586652228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.